Bone Biologics Corporation
BBLG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,325 | $3,027 | $7,538 | $6,675 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $329 | $580 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $536 | $382 | $377 | $0 |
| Total Curr. Assets | $3,861 | $3,738 | $8,495 | $6,675 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,861 | $3,738 | $8,495 | $6,675 |
| Liabilities | – | – | – | – |
| Payables | $373 | $361 | $105 | $100 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $784 | $0 |
| Other Curr. Liab. | $5 | $471 | $1,659 | $0 |
| Total Curr. Liab. | $378 | $831 | $2,548 | $100 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $378 | $831 | $2,548 | $100 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $1 | $15 | $10 |
| Retained Earnings | -$85,021 | -$80,909 | -$71,960 | -$70,476 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $88,502 | $83,815 | $77,907 | $77,041 |
| Total Equity | $3,484 | $2,906 | $5,947 | $6,575 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,861 | $3,738 | $8,495 | $6,675 |
| Net Debt | -$3,325 | -$3,027 | -$7,538 | -$6,675 |